A study in mice deficient in AQP4 showed that AQP4 inhibition may provide a new therapeutic option for reducing brain edema in a wide variety of cerebral disorders [71], which suggests that AQP4 could be a potential target for cerebral ischemia. This evidence concerns the gene AQP4 and brain ischemia.